Document is current
Any future updates will be listed below
-
Authors
Gustafsson, Stefan https://orcid.org/0000-0001-5894-0351
Gedon, Daniel https://orcid.org/0000-0003-4397-9952
Lampa, Erik https://orcid.org/0000-0002-3268-8810
Ribeiro, Antônio H. https://orcid.org/0000-0003-3632-8529
Holzmann, Martin J.
Schön, Thomas B. https://orcid.org/0000-0001-5183-234X
Sundström, Johan https://orcid.org/0000-0003-2247-8454
-
Funding
Funding for this research was provided by:
Anders Wiklöf
Uppsala University
The Kjell and Märta Beijer Foundation
Wallenberg AI, Autonomous Systems and Software Program (WASP) funded by the Knut and Alice Wallenberg Foundation
Uppsala University
- License Information
-
More Information
Article History
Received: 8 August 2022
Accepted: 11 November 2022
First Online: 15 November 2022
Competing interests
: J.S. reports stock ownership in companies providing services to Itrim, Amgen, Janssen, Novo Nordisk, Pfizer, Takeda, AstraZeneca and Vifor Pharma, outside the submitted work. S.G. is employed at Sence Research AB. The other authors report no conflicts of interest.
